Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation to: ...

ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...

Valvular heart disease decreases the survival rate in cancer patients. Valve replacement surgeries provide a key benefit up to 72% all-cause-mortality reduction.

For example, high-quality surveys from RAND find that teachers report higher levels of job-related stress and burnout than ...

Investing.com -- DBV Technologies stock surged 30% after the company announced positive results from its Phase III VITESSE clinical trial for VIASKIN Peanut, a treatment for peanut allergies in ...

Investing.com -- DBV Technologies (NASDAQ:DBVT) stock soared 65.2% in after-hours trading Tuesday following the announcement of positive topline results from its Phase 3 VITESSE trial for the VIASKIN ...

The use of medication during pregnancy carries a potential health risk, including childhood cancer, for the unborn child. However, most drugs examined in previous observational studies have ...

Detailed price information for Seabridge Gold Inc (SEA-T) from The Globe and Mail including charting and trades.

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...

Doubleview Gold is pleased to announce assay results from drill holes H097, H098, and H099 from its 2025 drill program at the Hat Polymetallic Deposit. Drill holes H097, H098 and H099 were collared ...